Our Resources | Association for Accessible Medicines

AAM Amicus Brief

Sep 6, 2024 | AAM

Amarin v. Hikma

2024 U.S. Generic and Biosimilar Medicines Savings Report

Sep 5, 2024 | AAM

Generic and Biosimilar Medicines Save $445 Billion in 2023

2024 U.S. Generic and Biosimilar Medicines Savings Report

Sep 5, 2024 | AAM

2024 Savings Report

Closeup cashless wireless payment with credit card at the pharmacy

Aug 15, 2024 | Ashley Henyan

Benefit Projected by CMS Price Setting Cannot Compare to Benefit of Generic and Biosimilar Medicines

Jul 9, 2024 | Brian Hart

FTC Report Critical of PBMs Highlights Middlemen Profits Over Patient Savings

Jun 26, 2024 | Ashley Henyan

Blog: Bill Addressing Drug Shortages Provides Long Overdue Relief from Penalties Hurting Generic Drug Market

Jun 25, 2024 | AAM

Senate Finance Committee Bill Addressing Drug Shortages Would Provide Long Overdue Relief from Penalties Hurting Generic Drug Market

Video

Jun 20, 2024 | Comms Temp

Join Us at Access! 2025 in Amelia Island, Florida

May 30, 2024 | Brian Hart

AAM Submits Comments to HHS and FTC on the Impact of GPOs and Wholesalers on Access to Generic Medicines

May 21, 2024 | Brian Hart

AAM Applauds Senate Judiciary Committee Efforts to Protect Patients and Skinny Labeling

Senior getting medicines at pharmacy counter

Apr 17, 2024 | Brian Hart

Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?

Video

Apr 16, 2024 | Aquera Agee

Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024